Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

March 2009; Volume 50,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Lewis, Valerae O.

    1. You have access
      18F-FDG PET/CT as an Indicator of Progression-Free and Overall Survival in Osteosarcoma
      Colleen M. Costelloe, Homer A. Macapinlac, John E. Madewell, Nancy E. Fitzgerald, Osama R. Mawlawi, Eric M. Rohren, A. Kevin Raymond, Valerae O. Lewis, Peter M. Anderson, Roland L. Bassett, Robyn K. Harrell and Edith M. Marom
      Journal of Nuclear Medicine March 1, 2009, 50 (3) 340-347; DOI: https://doi.org/10.2967/jnumed.108.058461
  2. Li, Fang

    1. You have access
      99mTc-HYNIC-TOC Scintigraphy Is Superior to 131I-MIBG Imaging in the Evaluation of Extraadrenal Pheochromocytoma
      Libo Chen, Fang Li, Hongming Zhuang, Hongli Jing, Yanrong Du and Zhengpei Zeng
      Journal of Nuclear Medicine March 1, 2009, 50 (3) 397-400; DOI: https://doi.org/10.2967/jnumed.108.058693
  3. Light, David R.

    1. You have access
      In Vivo Biodistribution, PET Imaging, and Tumor Accumulation of 86Y- and 111In-Antimindin/RG-1, Engineered Antibody Fragments in LNCaP Tumor–Bearing Nude Mice
      Douglas W. Schneider, Tara Heitner, Bruno Alicke, David R. Light, Kirk McLean, Noboru Satozawa, Gordon Parry, Jeongsoo Yoo, Jason S. Lewis and Renate Parry
      Journal of Nuclear Medicine March 1, 2009, 50 (3) 435-443; DOI: https://doi.org/10.2967/jnumed.108.055608
  4. Lipowska, Malgorzata

    1. You have access
      99mTc(CO)3-Nitrilotriacetic Acid: A New Renal Radiopharmaceutical Showing Pharmacokinetic Properties in Rats Comparable to Those of 131I-OIH
      Malgorzata Lipowska, Luigi G. Marzilli and Andrew T. Taylor
      Journal of Nuclear Medicine March 1, 2009, 50 (3) 454-460; DOI: https://doi.org/10.2967/jnumed.108.058768
  5. Litwin, Samuel

    1. You have access
      Pretargeted Versus Directly Targeted Radioimmunotherapy Combined with Anti-CD20 Antibody Consolidation Therapy of Non-Hodgkin Lymphoma
      Robert M. Sharkey, Habibe Karacay, Christine R. Johnson, Samuel Litwin, Edmund A. Rossi, William J. McBride, Chien-Hsing Chang and David M. Goldenberg
      Journal of Nuclear Medicine March 1, 2009, 50 (3) 444-453; DOI: https://doi.org/10.2967/jnumed.108.058602
  6. Lopresti, Brian

    1. You have access
      Consideration of Optimal Time Window for Pittsburgh Compound B PET Summed Uptake Measurements
      Rebecca L. McNamee, Seong-Hwan Yee, Julie C. Price, William E. Klunk, Bedda Rosario, Lisa Weissfeld, Scott Ziolko, Michael Berginc, Brian Lopresti, Steven DeKosky and Chester A. Mathis
      Journal of Nuclear Medicine March 1, 2009, 50 (3) 348-355; DOI: https://doi.org/10.2967/jnumed.108.057612
  7. Lu, Xin

    1. You have access
      Quantification of Tryptophan Transport and Metabolism in Lung Tumors Using PET
      Csaba Juhász, Otto Muzik, Xin Lu, M. Salik Jahania, Ayman O. Soubani, Majid Khalaf, Fangyu Peng, Thomas J. Mangner, Pulak K. Chakraborty and Diane C. Chugani
      Journal of Nuclear Medicine March 1, 2009, 50 (3) 356-363; DOI: https://doi.org/10.2967/jnumed.108.058776
  8. Macapinlac, Homer A.

    1. You have access
      18F-FDG PET/CT as an Indicator of Progression-Free and Overall Survival in Osteosarcoma
      Colleen M. Costelloe, Homer A. Macapinlac, John E. Madewell, Nancy E. Fitzgerald, Osama R. Mawlawi, Eric M. Rohren, A. Kevin Raymond, Valerae O. Lewis, Peter M. Anderson, Roland L. Bassett, Robyn K. Harrell and Edith M. Marom
      Journal of Nuclear Medicine March 1, 2009, 50 (3) 340-347; DOI: https://doi.org/10.2967/jnumed.108.058461
  9. Madewell, John E.

    1. You have access
      18F-FDG PET/CT as an Indicator of Progression-Free and Overall Survival in Osteosarcoma
      Colleen M. Costelloe, Homer A. Macapinlac, John E. Madewell, Nancy E. Fitzgerald, Osama R. Mawlawi, Eric M. Rohren, A. Kevin Raymond, Valerae O. Lewis, Peter M. Anderson, Roland L. Bassett, Robyn K. Harrell and Edith M. Marom
      Journal of Nuclear Medicine March 1, 2009, 50 (3) 340-347; DOI: https://doi.org/10.2967/jnumed.108.058461
  10. Maffei, Antonella

    1. You have access
      11C-Dihydrotetrabenazine PET of the Pancreas in Subjects with Long-Standing Type 1 Diabetes and in Healthy Controls
      Robin Goland, Matthew Freeby, Ramin Parsey, Yoshifumi Saisho, Dileep Kumar, Norman Simpson, Joy Hirsch, Martin Prince, Antonella Maffei, J. John Mann, Peter C. Butler, Ronald Van Heertum, Rudolph L. Leibel, Masanori Ichise and Paul E. Harris
      Journal of Nuclear Medicine March 1, 2009, 50 (3) 382-389; DOI: https://doi.org/10.2967/jnumed.108.054866
« Previous (Pages : 5 6 7 8 9 10 11 12 13 14 ... 17) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 50 (3)
Journal of Nuclear Medicine
Vol. 50, Issue 3
March 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire